|
Svensjö, Erik; Saraiva, Elvira M; Amendola, Rafael Silveira et al. (2012) Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway. Microvasc Res 83:185-93
|
|
Lerner, Ethan A; Yosipovitch, Gil (2010) A tribute to Walter Shelley, a pioneer itch researcher (1917-2009). Arch Dermatol 146:788
|
|
Lerner, Ethan A; Iuga, Aurel O; Reddy, Vemuri B (2007) Maxadilan, a PAC1 receptor agonist from sand flies. Peptides 28:1651-4
|
|
Iuga, Aurel O; Qureshi, Abrar A; Lerner, Ethan A (2004) Nitric oxide is toxic to melanocytes in vitro. Pigment Cell Res 17:302-6
|
|
Pereira, Phyllis; Reddy, Vermuri B; Kounga, Kounga et al. (2002) Maxadilan activates PAC1 receptors expressed in Xenopus laevis xelanophores. Pigment Cell Res 15:461-6
|
|
Reddy, V B; Kounga, K; Mariano, F et al. (2000) Chrysoptin is a potent glycoprotein IIb/IIIa fibrinogen receptor antagonist present in salivary gland extracts of the deerfly. J Biol Chem 275:15861-7
|
|
Lerner, L H; Qureshi, A A; Reddy, B V et al. (2000) Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J Invest Dermatol 114:196-9
|
|
Moro, O; Wakita, K; Ohnuma, M et al. (1999) Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J Biol Chem 274:23103-10
|
|
Moro, O; Lerner, E A (1997) Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J Biol Chem 272:966-70
|
|
Qureshi, A A; Hosoi, J; Xu, S et al. (1996) Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 107:815-21
|
Showing the most recent 10 out of 14 publications
